 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: September 2025
Volume 10 | Issue 9
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 10
Issue Published : 112
Article Submitted : 17586
Article Published : 7621
Total Authors : 20203
Total Reviewer : 740
Total Countries : 135
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | New Analytical Method Development and Validation of an RP-HPLC for the Determination of REMOGLIFLOZIN ETABONATE in Bulk and Pharmaceutical Dosage Form |
| Authors Name: | DILLAN KUMAR , Sreenivas Rao T , Chandanam Sreedhar , Kumari Khushboo , Harsha K. Tripathy |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_184503
|
| Published Paper Id: | IJRTI2210124 |
| Published In: | Volume 7 Issue 10, October-2022 |
| DOI: | |
| Abstract: | Background and objectives: This research work make an attempt to establish sensitive and accurate methods for the development and validation of analytical methods for estimation of Remogliflozin Etabonate in bulk and pharmaceutical dosage form. Methods: A mixture of 0.1% Triethylamine buffer pH 7.9 and methanol in the ratio of 70:30 (v/v%) was used as the mobile phase. A working standard solution of concentration 20 µg/ml was used. An XBridge™ C18 column 5µ (250 mm x 4.6 mm) was used for the analysis at a flow rate of 1 ml/min, injection volume of 20 µl, run time of 10 mins and detection wavelength of 227 nm. The repeatability (within-day in triplicates) and intermediate precision (for two days) were carried out by six injections and the obtained results within and between the days of trials were expressed as % RSD. The linearity of the method was determined by the analysis of analyte concentration across a range of 05μg/ml to 30μg/ml and area was plotted graphically as a function of analyte concentration. The accuracy of the method was determined by calculating recoveries of Remogliflozin Etabonate by the standard addition method. In a pre-quantified sample solution (20µg/ml), a known amount of standard solutions of Remogliflozin Etabonate (80%, 100% and 120%) were added. For robustness a change of ±0.1 ml/min and ±1 nm was done in flow rate and detection wavelength respectively. A signal to noise ratio 3:1 and 10:1 was considered for calculating LOD and LOQ respectively. Results: The %RSD values of precision studies were found to be below the accepted limit of 2%. The method was found to be linear with a correlation coefficient (r2) of 0.9999. The method was also found to be accurate and robust with suitable values. The LOD and LOQ of the method was found to be 0.42 µg/ml and 1.41 µg/ml respectively. Interpretation and conclusion: The results of analysis prove that this method can be used for the routine determination of Remogliflozin Etabonate in bulk drug and in pharmaceutical dosage forms. |
| Keywords: | Remogliflozin Etabonate, RP-HPLC, method development, validation, LOD, LOQ |
| Cite Article: | "New Analytical Method Development and Validation of an RP-HPLC for the Determination of REMOGLIFLOZIN ETABONATE in Bulk and Pharmaceutical Dosage Form", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 10, page no.1014 - 1020, October-2022, Available :http://www.ijrti.org/papers/IJRTI2210124.pdf |
| Downloads: | 000205020 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2210124
Registration ID:184503
Published In: Volume 7 Issue 10, October-2022
DOI (Digital Object Identifier):
Page No: 1014 - 1020 Country: Bangalore , Karnataka , India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2210124 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2210124 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2025 - All Rights Reserved - IJRTI | |||